Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma
Viral tumor models have significantly contributed to our understanding of oncogenic mechanisms. How transforming delta-retroviruses induce malignancy, however, remains poorly understood, especially as viral mRNA/protein are tightly silenced in tumors. Here, using deep sequencing of broad windows of...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 110; no. 6; pp. 2306 - 2311 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
05.02.2013
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Viral tumor models have significantly contributed to our understanding of oncogenic mechanisms. How transforming delta-retroviruses induce malignancy, however, remains poorly understood, especially as viral mRNA/protein are tightly silenced in tumors. Here, using deep sequencing of broad windows of small RNA sizes in the bovine leukemia virus ovine model of leukemia/lymphoma, we provide in vivo evidence of the production of noncanonical RNA polymerase III (Pol III)-transcribed viral microRNAs in leukemic B cells in the complete absence of Pol II 5′-LTR–driven transcriptional activity. Processed from a cluster of five independent self-sufficient transcriptional units located in a proviral region dispensable for in vivo infectivity, bovine leukemia virus microRNAs represent ∼40% of all microRNAs in both experimental and natural malignancy. They are subject to strong purifying selection and associate with Argonautes, consistent with a critical function in silencing of important cellular and/or viral targets. Bovine leukemia virus microRNAs are strongly expressed in preleukemic and malignant cells in which structural and regulatory gene expression is repressed, suggesting a key role in tumor onset and progression. Understanding how Pol III-dependent microRNAs subvert cellular and viral pathways will contribute to deciphering the intricate perturbations that underlie malignant transformation. |
---|---|
Bibliography: | http://dx.doi.org/10.1073/pnas.1213842110 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 1Present address: Department of Toxicogenomics, Maastricht University, 6200 MD Maastricht, The Netherlands. Author contributions: M.G. and A.V.d.B. designed research; N.R., M.M., K.D., H.T., F.C., Y.C., and C.V. performed research; N.R., F.M., E.W., M.G., and A.V.d.B. analyzed data; and N.R., F.M., A.B., M.G., and A.V.d.B. wrote the paper. Edited* by Robert C. Gallo, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, and approved December 14, 2012 (received for review August 21, 2012) |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.1213842110 |